AN2 Therapeutics | Investor Presentation Deck | 25 slides · page 18 of 25
The slide outlines a seamless transition between Phase 2 and Phase 3 trials for a specific drug candidate.
Pitch deck · roadmap · plan_implementation · dense density
Slide locked Sign in to view
Slide schematic 5/5
diagram 1/1 paragraph 1/1 source-note 1/1 table 1/1 title 1/1
Components 5
timeline paragraph source-note data headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1